About Sanjivani Paranteral Ltd
Sanjivani Paranteral is a research based, international pharmaceutical Group that provides a wide range of high-quality product and services, at affordable prices. The core product range of the Group's products includes oral solids, small volume parenteral and sterile powder formulations.
Founded
1994
CEO
Ashwin Khemka
Employees
40
HQ
Mumbai, India
Finished Products
1Sales
₹168.74Cr2Domestic Services
₹6.00Cr3JobWork Charges
₹3.85Cr4Export Incentive
₹1.17Cr5Export Services Charges
₹0.46CrRaw Materials
1Raw Materials consumed
₹80.59CrAbout Sanjivani Paranteral Ltd
Sanjivani Paranteral is a research based, international pharmaceutical Group that provides a wide range of high-quality product and services, at affordable prices. The core product range of the Group's products includes oral solids, small volume parenteral and sterile powder formulations.
Founded:1994
CEO:Ashwin Khemka
Employees:40
HQ:Mumbai, India
Finished Products
1Sales
₹168.74Cr2Domestic Services
₹6.00Cr3JobWork Charges
₹3.85Cr4Export Incentive
₹1.17Cr5Export Services Charges
₹0.46CrRaw Materials
1Raw Materials consumed
₹80.59CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹268
52W Low
₹126
Volume18.63K
Avg VolumeN/A
Beta0.98
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
32.02x
Valuation
P/B Ratio
4.95x
Valuation
EPS
₹6.07
Valuation
Dividend Yield
0.00%
Valuation
ROE
13.87%
Profitability
ROCE
16.29%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing pharmaceutical producRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.30x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
8.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.